{"transactions":[{"id":724993,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35035,"kind":"person","name":"Lawver Teri L","position":1,"cik":"0001960596","reported_name":"Lawver Teri L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Commercial Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:21:58.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":90000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001960596-26-000004","document":"form4-06292026_080655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000196059626000004/form4-06292026_080655.xml","form_type":"4"}},{"id":795413,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":35035,"kind":"person","name":"Lawver Teri L","position":1,"cik":"0001960596","reported_name":"Lawver Teri L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2026-05-01T20:23:16.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted pursuant to the Company's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":48800,"derivative":{"exercise_price":2.82,"expiration_date":"2036-05-01","underlying":"Common Stock, par value $0.0001","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0001960596-26-000002","document":"form4-05012026_080512.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000196059626000002/form4-05012026_080512.xml","form_type":"4"}},{"id":1003203,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35035,"kind":"person","name":"Lawver Teri L","position":1,"cik":"0001960596","reported_name":"Lawver Teri L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Commercial Officer"}}],"security":"ISO (right to buy)","published_at":"2025-11-12T21:12:27.000Z","date":"2025-11-10","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on November 10, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":100000,"derivative":{"exercise_price":22.67,"exercise_date":"2026-11-10","expiration_date":"2035-11-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001960596-25-000008","document":"form4-11122025_091122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000196059625000008/form4-11122025_091122.xml","form_type":"4"}},{"id":1031147,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":35035,"kind":"person","name":"Lawver Teri L","position":1,"cik":"0001960596","reported_name":"Lawver Teri L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2025-09-29T20:19:09.000Z","date":"2025-09-25","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 25, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":48800,"derivative":{"exercise_price":3.92,"expiration_date":"2035-09-25","underlying":"Common Stock, par value $0.0001","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0001104659-25-094497","document":"tm2527377-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925094497/tm2527377-7_4seq1.xml","form_type":"4"}},{"id":1242728,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":35035,"kind":"person","name":"Lawver Teri L","position":1,"cik":"0001960596","reported_name":"Lawver Teri L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2025-02-26T23:47:43.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":69800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments following February 24, 2025 subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":69800,"derivative":{"exercise_price":6.11,"expiration_date":"2035-02-24","underlying":"Common Stock, par value $0.0001","underlying_shares":69800},"source":{"system":"sec-edgar","filing":"0001104659-25-017580","document":"tm257585-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925017580/tm257585-4_4seq1.xml","form_type":"4"}},{"id":1577172,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":35035,"kind":"person","name":"Lawver Teri L","position":1,"cik":"0001960596","reported_name":"Lawver Teri L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-14T21:39:49.000Z","date":"2024-03-12","kind":"sale","planned":false,"acquired":false,"shares":4764,"price":134.4107,"value":640332.5748,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 60,067 unvested restricted stock units, 26,053 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 34,014 of which were granted on March 8, 2023 and shall vest through March 8, 2027."}],"balance_after":66641,"source":{"system":"sec-edgar","filing":"0001093557-24-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355724000050/edgardoc.xml","form_type":"4"}},{"id":1584887,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":35035,"kind":"person","name":"Lawver Teri L","position":1,"cik":"0001960596","reported_name":"Lawver Teri L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-11T22:31:18.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":26053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant.  Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 60,067 unvested restricted stock units, 26,053 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 34,014 of which were granted on March 8, 2023 and shall vest through March 8, 2027."}],"balance_after":71405,"source":{"system":"sec-edgar","filing":"0001093557-24-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355724000036/edgardoc.xml","form_type":"4"}},{"id":1959479,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":35035,"kind":"person","name":"Lawver Teri L","position":1,"cik":"0001960596","reported_name":"Lawver Teri L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-10T21:00:01.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":45352,"price":0.001,"value":45.352,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in four equal annual installments from the date of grant.  Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 45,352 unvested restricted stock units, 45,352 of which were granted on March 8, 2023 and shall vest through March 8, 2027."}],"balance_after":45352,"source":{"system":"sec-edgar","filing":"0001093557-23-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000055/edgardoc.xml","form_type":"4"}}]}